SPS
TMCI icon

Susquehanna Portfolio Strategies’s Treace Medical Concepts TMCI Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Buy
+137,135
New +$273K ﹤0.01% 909
2025
Q4 		– Sell
-13,925
Closed -$93.4K – 1128
2025
Q3 		$93.4K Buy
+13,925
New +$90.9K ﹤0.01% 1008

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Portfolio Strategies's TMCI Position: Q1 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Treace Medical Concepts (TMCI) in Q1 2026: 137,135 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in TMCI as recently as Q3 2025.

Susquehanna Portfolio Strategies first reported a position in TMCI in Q3 2025 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Susquehanna Portfolio Strategies held 137,135 shares of Treace Medical Concepts worth $184K as of Q1 2026.
  • Treace Medical Concepts was a new Susquehanna Portfolio Strategies position in Q1 2026.
  • Treace Medical Concepts made up ﹤0.01% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #909 holding.
  • Susquehanna Portfolio Strategies first reported a position in Treace Medical Concepts in Q3 2025 and has held it in 2 quarters since.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.